Odile Prigneau
Amministratore Delegato presso Prestizia SASU
Profilo
Odile Prigneau is currently the Chief Executive Officer at Prestizia SASU since 2013.
Prior to this, she worked as the Director of Marketing and Business Development at Theradiag SA. She holds a doctorate degree from the Université de Paris 5 René Descartes.
Posizioni attive di Odile Prigneau
| Società | Posizione | Inizio |
|---|---|---|
Prestizia SASU
 Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Amministratore Delegato | 18/09/2013 |
Precedenti posizioni note di Odile Prigneau
| Società | Posizione | Fine |
|---|---|---|
| THERADIAG | Corporate Officer/Principal | - |
Formazione di Odile Prigneau
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Prestizia SASU
Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Commercial Services |
- Borsa valori
- Insiders
- Odile Prigneau
